© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
CE: Innovations in Acute Graft-Versus-Host Disease: Pharmacy Updates on Risk Assessment, Prevention, and Treatment
Pharmacy Times Oncology Edition, February 2021, Volume 3, Issue 1
This activity is supported by an educational grant from Incyte Corporation.
This activity is supported by an educational grant from Incyte Corporation.
EDUCATIONAL OBJECTIVES
At the completion of this activity, the participant will be able to:
- Apply risk scoring tools for assessing grade and stage of acute graft-versus-host disease (aGVHD) in allogeneic hematopoietic stem cell transplantation (HSCT) recipients
- Examine emerging strategies in the prevention and treatment of aGVHD
- Maximize the role of the pharmacist of the HSCT team to improve patient outcomes
FACULTY
Nicole Watts, PharmD, BCOP
Clinical Pharmacy Specialist, Blood and Bone Marrow Transplant , University of Alabama at Birmingham Hospital , Birmingham, Alabama
TARGET AUDIENCE: Pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: November 30, 2020
EXPIRATION DATE: August 30, 2021
ESTIMATED TIME TO COMPLETE ACTIVITY: 2 hours
FEE: This lesson is offered for free at www.pharmacytimes.org.